Welcome to the Fall issue of ISPOR News Across EMEA, the quarterly publication that brings you the latest updates on HEOR and health policy from different perspectives in the EMEA region and includes news from ISPOR Regional Chapters, and updates from ISPOR‘s HQ office.
A featured article of the issue brings insights on social health insurance as an alternative financing mechanism for healthcare in Ethiopia addressing willingness to join and pay among public employers and healthcare providers. In this issue, you will also learn about global experiences with the use of HTA for health benefit packages development – read the details from the webinar organized with joint contribution and support from the ISPOR Central and Eastern Europe, Latin America and Asia Pacific Consortia.
We will also advise how to make the best out of the wealth of knowledge offered by the Virtual ISPOR Europe 2020 conference. This year’s virtual format offers both networking experience combined with a range of HEOR content offered during the regular days of the event (16-19 November 2020) and access to on-demand content now. We look forward to your participation – be part of the conversation by using #ISPOREurope!
As always, we encourage you to share the ISPOR News Across EMEA newsletter with your ISPOR Chapter members and colleagues and welcome your contribution, comments, and questions about ISPOR – you may contact us at firstname.lastname@example.org.
Enjoy this edition and thank you for your continuous engagement at ISPOR’s upcoming events and activities.
ISPOR Global Networks – EMEA Team
- “Social Health Insurance as An Alternative Financing Mechanism for Healthcare in Ethiopia: Willingness to Join and Pay Among Public Employers and Healthcare Providers”
- “Global Experiences with the Use of HTA for Health Benefit Packages Development”
The newly designed Virtual ISPOR Europe 2020 includes a series of on demand sessions leading up to the conference, available now, in addition to 4 days of live virtual programming, and a subscription to access all content through 31 December 2020. (All sessions presented in Central European Time – UTC +1).
- In addition to three plenary sessions, ISPOR Europe 2020 will include spotlight sessions highlighting timely topics in HEOR and promote innovation areas of interest to the HEOR community, breakout sessions with issue panels and workshops, educational symposia, poster presentations, networking opportunities and more.
- ISPOR Global Networks presentations during ISPOR Virtual Europe 2020, will bring to you the opportunity to stay aware of relevant topics in Asia Pacific, Latin America, and EMEA regions. For this conference you’ll have access to both on demand and live group discussion sessions. We hope you can participate in the activities that we have prepared for you:
On Demand “The Transferability of Health Technology Assessment: The European Perspective with Focus on Central and Eastern European Countries”: Presented by the ISPOR CEE Consortium
Group discussion “Effect of Public and Private Partnership in Healthcare Financing to Improve Health Outcomes”: Presented by the ISPOR Arabic Network
- Asia Pacific:
On Demand “Real-World Evidence for Medtech Value Assessment in Asia Pacific – Where are we Heading?”: Presented by the ISPOR Asia Consortium Industry Committee
- Latin America:
On Demand “Practical Applications: How HEOR is Advancing Access, Value and Affordability in Healthcare in Latin America”: Presented by the ISPOR Latin America Consortium
For more information visit the Conference program here.
HEOR/HEALTH POLICY UPDATES FROM EMEA REGION
- European Commission Key Initiatives – The European Commission (EC) has hosted a virtual webinar entitled “Science advice and COVID-19: What are we learning?” on September 16, 2020. This global dialogue focused on how effectively Europe is rising to the challenge and what lessons can be learned for the future. The EC chief scientific advisors, experts and staff shared practical experiences of giving science advice in the face of unprecedented complexity, uncertainty and public visibility during the outbreak, as well as how best to apply science advice frameworks and practices to secure greater resilience in the aftermath of COVID-19. More information is available here.
- The Health Policy Platform hosted a webinar on “EU Vaccine Strategy” with a keynote speech from Stella Kyriakides, European Commissioner for Health and Food Safety on 18 September. The objective of this webinar is to inform a wide audience of health stakeholders about the general commission strategy on vaccination for COVID-19 and on the initiatives taken over the last weeks to secure a supply of safe and efficacious future vaccines. Read more…
- The European Commission published its evaluation on the legislation for medicines for rare diseases and for children on 11 August 2020. This is the first comprehensive evaluation of the two regulations since their adoption in 2000 and 2006 respectively. The evaluation aimed to assess the strengths and weaknesses of the two regulations. The evaluation consisted of several steps, including the publication of a roadmap, various recent studies on pediatric medicines and on medicines for orphan diseases and extensive consultation of stakeholders. More information here.
- The European Centre for Disease Prevention and Control (ECDC) a workshop “Unlocking the potential of data in light of early lessons from COVID-19” on 2 October at European Health Forum Gastein 2020. The global experts and policymakers discussed how early lessons learnt from the COVID-19 pandemic can be translated into a roadmap for strengthening health systems and overall research and public health endeavors in the EU. More information can be accessed via the link.
- European Network for Health Technology Assessment (EUnetHTA) publishes reviews for available therapies for Covid-19 pandemic – EUnetHTA has recently published its first “rolling collaborative reviews” for 14 pharmaceutical and non-pharmaceutical therapies available for COVID-19. These publications aim to provide up-to-date information to health decision-makers at national/regional/European level and to facilitate the development of HTA reports to be carried out either by EUnetHTA or individual agencies. For more information click here.
- African island states launch joint medicines procurement initiative -The Ministers of Health from seven small African island states signed an agreement on 29 September 2020 for pool procurement of drugs and vaccines to strengthen access to medicines and the quality of procured health products. The agreement, which is the result of several years of laborious effort, is expected to improve the purchasing power of these small nations by pooling collective resources and increasing the attractiveness of the market for innovators, and ultimately harmonize medicines management systems, improve supplier performance and reduce procurement work load. “By creating a larger stream of demand, we can look forward to better access to quality and competitively-priced medicines. The high cost of medicines is one of the major barriers many countries in our region face in providing affordable health care of good standard. Pooling our resources is one way of overcoming this challenge,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. For more information, please visit here.
- Nigerian Government Launches new RMNCAEH+N platform – The Nigerian Minister of Health, Dr Osagie Ehanire, recently launched the Nigeria Reproductive, Maternal, Newborn, Child, Adolescent and Elderly Health Plus Nutrition (RMNCAEH+N) on 12 October, 2020, which will be a multi-stakeholder platform aiming to synergize management of public and private health resources to reduce waste and optimize resource utilization, to attain effective Universal Health Coverage in the country. The Government expressed dissatisfaction with the national health system’s current performance and see this initiative as a key to strengthening the system. “Our health indices are unacceptably poor and there are emerging issues around gender, public health emergencies and, most recently, the COVID-19 pandemic. Glaring limitations in achieving equitable access to quality Reproductive, Maternal, Newborn, Child, Adolescent and Elderly Health Plus Nutrition (RMNCAEH+N) is also a key area of concern for global health and security,” said Dr Ehanire. Indeed, the maternal and child health indices in the country are a cause for concern – according to a Nigeria Demography and Health Survey from 2018 indicated high maternal and infant mortality ratios compared to global benchmarks. For more information, please visit here.
- Regulatory and Unified Approach in Africa of New Medicines and Vaccines -To provide a more unified approach to regulatory approval of new medicines and vaccines and improve access to medical products in Africa, many countries in the region signed a treaty establishing an African Medicines Agency last year. Head of African CDC, John Nkengasong urged more countries to sign it. You can read more about it here.
- The European Commission (EC) continues to work with Member States to provide more coronavirus testing kits to the Africa Centers for Disease Control and Prevention in Addis Ababa, Ethiopia to support the African Union’s response to coronavirus. Mr. Gerd Müller, Minister of Development Cooperation of the Federal Republic of Germany, said: “We will either beat the coronavirus together worldwide – or not at all”. Please visit here to learn more
Second National HTA Forum and HTAi meeting in Ukraine
Oresta Piniazhko, PhD, President of ISPOR Ukraine Chapter, Olha Zaliska, Founder and Past President of ISPOR Ukraine Chapter, and Khmelovska M., MEcon, Expert of the division of economic evaluation of medicines of HTA Department at State Expert Centre of MoH Ukraine
The 2nd National Health Technology Assessment Forum in Ukraine was held on September 24-25, 2020. This forum was organized by the Ministry of Health and with collaboration of the USAID’s SAFEMed project. About 120 stakeholders, from government, academia and patient’s organizations as well as industry representatives participated in a discussion with the objective of updating the HTA roadmap in Ukraine, as a sustainable, reliable and independent HTA function. Some of the topics discussed as panels were “Towards Independent Agency: Exploring Legal Framework on HTA” and “Towards Positive List in Ukraine and how HTA can be integrated,” and additional discussions were presented as workshops with the topics “HTA to overcome financial and economic barriers to market access”, “Patient communication and engagement”, and “Education/capacity building” also featured.
During September 8-11, 2020 the HTAi Regional meeting took place. This was a virtual event celebrated in Kyiv, Ukraine. Participants received HTA training followed by a workshop with the intention of building regional HTA experiences and facilitated the continuous cycle needed to develop HTA capacity. Dr Oresta Piniazhko and Professor Olha Zaliska, were active participants of both events. Visit the chapter’s website to learn more about this and other activities.
The ISPOR South Africa Chapter will be holding its 9th Chapter Conference virtually on November 2020. The event features international and national expert speakers and its topics focus on value Assessment Framework for Health and Alternative Reimbursement. The registration information and the meeting agenda are available here
ISPOR’s Value in Health Regional Issues Articles in Press
Value in Health Regional Issues – CEEWAA (Central and Eastern Europe, Western Asia and Africa) 2020 was published in September 2020, several articles are available for viewing:
- Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece Panagiota Naoum, Kostas Athanasakis, Anastasis Skroumpelos, John Kyriopoulos
- Making Connections and Measuring Performance: Bibliometric Analysis of Multi-Attribute, Preference-Based Health-Related Quality of Life Research in South Africa Sophia E. Marsh
- The Cost-Effectiveness of Abdominal Aortic Aneurysm Screening in Estonia Rainer Reile, Triin Võrno, Jaak Kals, Pilvi Ilves, Raul-Allan Kiivet
- Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema Faris El-Dahiyat, Islam Eljilany
- Evaluation of Psychometric Quality of EQ-5D-5L Scale for Assessing Health-Related Quality of Life of Malaria Patients Nanloh S. Jimam, Nahlah E. Ismail, Wetkos D. Dayom
- Valuing Health State: An EQ-5D-5L Value Set for Ethiopians Abraham G. Welie, Gebremedhin Beedemariam Gebretekle, Elly Stolk, Clara Mukuria, Murray D. Krahn, Fikre Enquoselassie, Teferi Gedif Fenta
The Real-World Evidence Transparency Initiative Publishes Article on Improving Transparency and Trust in Non-interventional Research for Hypothesis Testing – The steering committee of the Real-World Evidence Transparency Initiative published a paper entitled “Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative” in the September 2020 issue ofValue in Health. The paper highlightsthe views and recommendations for improving real-world evidence transparency, especially for hypothesis evaluating treatment effect studies done with secondary data sources. Click here to read the full article.
ISPOR Health Preference Research Special Interest Group Publishes Report – A recent report titled “Health Preference Research in Europe – A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions: Report of the ISPOR Stated Preference Research Special Interest Group” was published in July’s Value in Health themed issue on health preference research. To access the article, please click here. For more information on this special interest group, please click here.
ISPOR MEMBER NEWS AND ENGAGEMENT OPPORTUNITIES
ISPOR 51st Health Technology Assessment Roundtable – Middle East & Africa – The ISPOR HTA Roundtable-Middle East & Africa convened on 8 October virtually. Eighteen attendees from 13 different countries met to discuss the status of HTA implementation in their own countries. In addition to an open discussion among participants, there were didactic components. The meeting began with a training on budget impact analysis from representatives of VI Research, followed by a presentation on the use of cost effectiveness thresholds by the National Institute for Health and Care Excellence. For more information on ISPOR HTA roundtables, please visit here.
Congratulations to ISPOR Mexico Chapter, ISPOR Mongolia Chapter, and ISPOR Austria Chapter for being recognized with the ISPOR 2020 Outstanding Regional Chapter Award. TheISPOR Outstanding Regional Chapter Award recognizes outstanding contributions and leadership of ISPOR Regional Chapters in advancing the ISPOR mission in ISPOR global regions. The award is offered in small, medium, and large Chapter categories. Stay tuned for the special featured interviews with this year’s awardees in ISPOR Value & Outcomes Spotlight magazine this November/December 2020. Lessons learned during COVID-19 and how they see the future of healthcare and the role of HEOR on the post-pandemic world were some of the questions that we queried them regarding. To learn more about this award click here.
Chapter Leader Training 2020 – These interactive trainings are designed for ISPOR Regional Chapter and ISPOR Consortium leaders to support capacity building and leadership development. The trainings provide information on recent trends related to HEOR methodology or health policy, and they also equip ISPOR leaders with techniques to be successful in their ISPOR leadership roles.
ISPOR Chapter Leadership Training 2020:
- The 4th Industrial Revolution, Digital Transformation and Patient Centricity: A Leadership View – When: 15 December, 2020 at 10:00 AM Eastern Time (US and Canada)- Click here to register!
In this presentation we will explore what the 4th Industrial Revolution is, how it impacts on the progressive movement towards digital transformation in our workplace. We will show that there is an inevitable convergence between the health ecosystem and the digital world. Importantly we will link these disruptive changes to how it might advance patient centric approaches in our work and what leaders should be prepared for, how to equip themselves and practical examples to embrace this change. Given our leadership roles in our Chapters, examples and experience of how to lead this change successfully will be explored from a Chapter and Global experience.
Did you miss the additional trainings offered this year? You still have an opportunity to watch them on-demand:
- The Leader’s Vision: Value-Based Medicine and Leadership Training – 28 April 2020. 9:00 AM EST. Presented in Spanish. – Click here to see the recorded webinar
- Role of Digital Therapeutics in Reshaping the Future of Healthcare – 15 July 2020. 8:00 AM EST. Click here to see the recorded webinar. and read the summary here.
Recent Global Networks Webinars:
Focused on Asia Pacific:
- Patient Reported Outcomes in Asia Pacific: Opportunity and Challenges – Hosted by the Asia Consortium. Speakers from Japan, Taiwan, and Hong Kong discussed the importance, strengths, and limitations of patient-reported outcomes. Watch the webinar here.
Foused on Latin America:
- The Usage of Real-World Evidence (RWE): Monitoring and Managing Health Technologies in Latin America – Where We Are and Where We Are Heading. – This webinar described the Latin American trends in the use of RWE, and outlined the current stage, challenges, and opportunities for the use of it in the regional decision-making process as well as described the technical challenges for RWE from both global and regional perspectives. Watch the webinar here.
Educational Webinar Offerings from ISPOR Special Interest Groups:
- Why and How to Use Qualitative Research Methods in Conjunction with Discrete Choice Experiments in Health Care
- Open Source Models in HEOR: Benefits, Challenges, and ISPOR Members’ Perceptions
- Recordings coming soon to the ISPOR Webinars webpage:
- “Biosimilars: Unleashing the Potential for Improved Patient Access and Cost Savings in the United States”
- “One Health Perspectives on HEOR”
- “Patient-Reported Outcomes: Development, Use and Patient Engagement” – a 3-part webinar series
- ISPOR Women in HEOR Initiative
As you all know, the COVID-19 pandemic has upended the careers and personal lives of millions across the globe. In the upcoming weeks, leaders of the ISPOR Women in HEOR Initiative will be launching polls on how HEOR professionals can transition to the next phase of the “new normal” with an eye towards long-term career success. These polls will be available on ISPOR Women in HEOR LinkedIn Discussion Group. We encourage all to interact with the polls and share your strategies for balancing work and personal wellness in this evolving COVID-19 working world. The results of these polls will guide a live panel discussion titled “Adapting to the ‘New Normal’” at the upcoming Virtual ISPOR Europe 2020 conference (16-19 November 2020). To register for the Conference, please click here: www.ispor.org/Europe2020. For more information on the Initiative, please click here: www.ispor.org/WomenInHEOR
- Virtual ISPOR-FDA Summit 2020
On 29 September 2020, ISPOR and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) presented their jointly developed Virtual ISPOR-FDA Summit 2020, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond.” This Summit provided a forum to engage all stakeholders including patient representatives, medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators, who discussed and explored the role, challenges, and opportunities of using patient-preference information across the healthcare ecosystem. Full Summit content, including the recording of all sessions, speaker slides, and transcript, will be publicly available online on the ISPOR and FDA CDRH webpages by the end of October 2020. Also consider viewing an ISPOR Educational Webinar on this topic: Patient-Preference Information – What It Is and What It Is Not.
- Join us in the new ISPOR COVID-19 Member Community, an exclusive benefit available only for ISPOR members. The ISPOR COVID-19 Community is an exciting collaborative platform where you can share ideas, discuss challenges, and post questions related to COVID-19.
- Update from the ISPOR Task Forces – The ISPOR Measurement Comparability Between Modes of Administration of PROMs Good Practices Task Force presented “When Does Mode of Data Collection Matter? Updated and Expanded Recommendations for Collecting PRO Measures Electronically in Clinical Trials.” The slides and presentation are available: here.
- ISPOR Patient Centered Special Interest Group Reports and Webinar
The ISPOR Patient-Centered Special Interest Group recently launched a consensus definition of “Patient Engagement in Research”, representing a significant achievement for the group. Below are various channels through which this work has been disseminated. All content is available open access, without paywall. If you have examples or reflections on how you have implemented the new “Patient Engagement in Research” definition, we want to hear from you! Please share your successes, challenges, and use cases with us by emailing to email@example.com.
- “Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group” Value in Health Vol 22, Issue 6 | ISPOR Press Release.
- “From the Patients: Defining Patient Engagement in Research “, Value and Outcomes Spotlight July/August 2020 .
- “Patient Engagement in Research: An ISPOR Definition” Educational Webinar, on-demand July 17, 2020
There is more!
To learn about the latest HEOR news in Asia Pacific and Latin America, and read about activities and initiatives of ISPOR global groups in these regions, please access the November 2020 issues of News Across Asia-Pacific / November 2020 issue of News Across Latin America.
ISPOR News Across provides a valuable platform for information sharing for readers and advertisers alike. The ISPOR News Across editions are highly read by our ISPOR members and key opinion leaders globally, and there are opportunities to participate by advertising digitally in these publications in 2 different formats – 1) a horizontal banner (600×180 pixels) at $800, or 2) a small rectangle (300×250 pixels) at $500. Please contact firstname.lastname@example.org for more information.
ABOUT ISPOR GLOBAL NETWORKS – EMEA
ISPOR Global Networks EMEA represents regional groups affiliated with ISPOR that promote research, development and practice focusing on the advancement of health economics and outcomes research in Europe, Middle East, and Africa through educational, research, and policy-related activities to improve decision making for health. ISPOR Global Networks – EMEA encompasses 2 regional networks: Arabic and Africa, and Central & Eastern Europe Consortium, 41 Regional Chapters and works with close to 5000 members representing research, academia, industry, healthcare policy makers, regulators, health economists and patients in this global region.
ISPOR, the professional society for Health Economics and Outcomes Research (HEOR), is an international, multi-stakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.